Literature DB >> 28951066

The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen.

Geoffrey R Nunns1, Ernest E Moore2, Michael P Chapman3, Hunter B Moore1, Gregory R Stettler1, Erik Peltz1, Clay C Burlew4, Christopher C Silliman5, Anirban Banerjee1, Angela Sauaia6.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) patients have increased rates of bleeding as well as thrombosis. Fibrinogen and platelets combine to generate a mature clot, but in CKD platelets are dysfunctional. Therefore, we hypothesize that CKD patients have increased clot strength due to elevated fibrinogen levels.
METHODS: Retrospective review of CKD patients (n = 84) who had rTEG and fibrinogen levels measured. They were compared to healthy controls (n = 134).
RESULTS: CKD patients had statistically significant increases in ACT, angle, MA and decreases in LY30 compared to controls. Fibrinogen levels were increased in CKD patients compared to reference range. Fibrinogen levels had a positive correlation with MA (rho = 0.709, p < 0.0001) in CKD patients.
CONCLUSIONS: Patients with CKD manifest a coagulopathy consisting of delayed clot formation, but increased final clot strength and decreased clot breakdown. Furthermore, the elevated clot strength is mediated by increased fibrinogen levels in CKD patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic; Fibrinogen; Hypercoagulability; Kidney failure; TEG

Mesh:

Year:  2017        PMID: 28951066      PMCID: PMC5693753          DOI: 10.1016/j.amjsurg.2017.08.039

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  The effect of fibrinogen concentrate on thrombocytopenia.

Authors:  C Velik-Salchner; T Haas; P Innerhofer; W Streif; W Nussbaumer; A Klingler; G Klima; U Martinowitz; D Fries
Journal:  J Thromb Haemost       Date:  2007-05       Impact factor: 5.824

2.  Thrombelastography of blood from subjects with chronic renal failure.

Authors:  D S Holloway; J P Vagher; J A Caprini; N M Simon; L F Mockros
Journal:  Thromb Res       Date:  1987-03-15       Impact factor: 3.944

3.  Fibrin breakdown products and fibrinolysis in renal disease.

Authors:  E N Wardle; G Taylor
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

Review 4.  Hemostasis in renal disease: pathophysiology and management.

Authors:  M E Eberst; L R Berkowitz
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

5.  Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients.

Authors:  Jeffry L Kashuk; Ernest E Moore; Allison Sabel; Carlton Barnett; James Haenel; Tuan Le; Michael Pezold; Jerry Lawrence; Walter L Biffl; C Clay Cothren; Jeffrey L Johnson
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

6.  Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.

Authors:  N D Vaziri; E C Gonzales; J Wang; S Said
Journal:  Am J Kidney Dis       Date:  1994-06       Impact factor: 8.860

7.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.

Authors:  Herbert Schöchl; Ulrike Nienaber; Georg Hofer; Wolfgang Voelckel; Csilla Jambor; Gisela Scharbert; Sibylle Kozek-Langenecker; Cristina Solomon
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

Review 8.  Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature.

Authors:  Yue Dai; Anna Lee; Lester A H Critchley; Paul F White
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

Review 9.  The place of viscoelastic testing in clinical practice.

Authors:  Gregory A Hans; Martin W Besser
Journal:  Br J Haematol       Date:  2016-01-28       Impact factor: 6.998

Review 10.  Haemostasis in chronic kidney disease.

Authors:  Jens Lutz; Julia Menke; Daniel Sollinger; Helmut Schinzel; Klaus Thürmel
Journal:  Nephrol Dial Transplant       Date:  2013-10-16       Impact factor: 5.992

View more
  9 in total

1.  Effects of Blood Components and Whole Blood in a Model of Severe Trauma-Induced Coagulopathy.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  J Surg Res       Date:  2020-12-02       Impact factor: 2.192

2.  Association between fibrinogen/albumin ratio and severity of coronary artery calcification in patients with chronic kidney disease: a retrospective study.

Authors:  Yuyu Zhu; Shuman Tao; Danfeng Zhang; Jianping Xiao; Xuerong Wang; Liang Yuan; Haifeng Pan; Deguang Wang
Journal:  PeerJ       Date:  2022-06-06       Impact factor: 3.061

3.  Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.

Authors:  Nathaniel R Smilowitz; Nipun Bhandari; Jeffrey S Berger
Journal:  Atherosclerosis       Date:  2019-12-24       Impact factor: 5.162

4.  Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein-losing nephropathy.

Authors:  Sarah Shropshire; Tyler Johnson; Christine Olver
Journal:  J Vet Intern Med       Date:  2020-01-25       Impact factor: 3.333

Review 5.  Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review.

Authors:  Mark Walsh; Ernest E Moore; Hunter B Moore; Scott Thomas; Hau C Kwaan; Jacob Speybroeck; Mathew Marsee; Connor M Bunch; John Stillson; Anthony V Thomas; Annie Grisoli; John Aversa; Daniel Fulkerson; Stefani Vande Lune; Lucas Sjeklocha; Quincy K Tran
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

6.  Risk Factors in Hospitalized Patients for Heparin-Induced Thrombocytopenia by Real World Database: A New Role for Primary Hypercoagulable States.

Authors:  Jasmeet Kaur; Camelia Arsene; Sumeet Kumar Yadav; Olusola Ogundipe; Ambreen Malik; Anupam Ashutosh Sule; Geetha Krishnamoorthy
Journal:  J Hematol       Date:  2020-08-04

7.  Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection.

Authors:  Yuzuru Sakamoto; Shingo Shimada; Toshiya Kamiyama; Ko Sugiyama; Yoh Asahi; Akihisa Nagatsu; Tatsuya Orimo; Tatsuhiko Kakisaka; Hirofumi Kamachi; Yoichi M Ito; Akinobu Taketomi
Journal:  World J Gastrointest Surg       Date:  2022-07-27

8.  Radiocephalic Arteriovenous Fistula Patency and Use: A Post Hoc Analysis of Multicenter Randomized Clinical Trials.

Authors:  Patrick Heindel; Peng Yu; Jessica D Feliz; Dirk M Hentschel; Steven K Burke; Mohammed Al-Omran; Deepak L Bhatt; Michael Belkin; C Keith Ozaki; Mohamad A Hussain
Journal:  Ann Surg Open       Date:  2022-08-23

9.  The use of thromboelastography to assess post-operative changes in coagulation and predict graft function in renal transplantation.

Authors:  Carson B Walker; Hunter B Moore; Trevor L Nydam; Alexander C Schulick; Hillary Yaffe; James J Pomposelli; Michael Wachs; Thomas Bak; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Peter Kennealey
Journal:  Am J Surg       Date:  2020-08-27       Impact factor: 2.565

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.